{{Rsnum
|rsid=8004738
|Gene=SERPINA1
|Chromosome=14
|position=94390577
|Orientation=plus
|GMAF=0.4532
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SERPINA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.7 | 45.0 | 23.3
| HCB | 39.0 | 51.2 | 9.8
| JPT | 25.6 | 51.3 | 23.1
| YRI | 55.8 | 32.7 | 11.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 39.0 | 51.2 | 9.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID|21067581|OA=1
}} finds no association between [[rs8004738]] and pulmonary emphysema

{{PMID Auto
|PMID=21138453
|Title=Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma
}}

{{PMID Auto
|PMID=20170533
|Title=Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study.
|OA=1
}}

{{PMID Auto
|PMID=20808897
|Title=Disease-associated mutations that alter the RNA structural ensemble.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}